NCT06537349View on ClinicalTrials.gov

Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye

NANot yet recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

December 15, 2024

Study Completion Date

December 31, 2024

Conditions
Dry Eye
Interventions
DRUG

3% Diquafosol tetrasodium

3% Diquafosol tetrasodium eye drops will be used to assess its usefulness in OK lens related dry eye

All Listed Sponsors
lead

He Eye Hospital

OTHER

NCT06537349 - Effects of 3% Diquafosol on Tear Film and Vision-related Quality of Life in Orthokeratology Lens Related Dry Eye | Biotech Hunter | Biotech Hunter